Dr. Scott Paulson, MD
Claim this profileTexas Oncology
Area of expertise
Pancreatic Cancer
Scott Paulson, MD has run 7 trials for Pancreatic Cancer. Some of their research focus areas include:
Colorectal Cancer
Scott Paulson, MD has run 5 trials for Colorectal Cancer. Some of their research focus areas include:
Affiliated Hospitals
Texas Oncology
Scott Paulson
Clinical Trials Scott Paulson, MD is currently running
ACE2016
for Metastatic Tumors
ACE2016 is an off-the-shelf, allogeneic gamma delta T (gdT) cell therapy derived from healthy donors, that is under investigation for the treatment of Locally Advanced or Metastatic Solid Tumors Expressing Epidermal Growth Factor Receptor (EGFR). The ACE2016-001 study is an open-label, Phase I, first-in-human (FIH) study that aims to evaluate the safety and tolerability, persistency, pharmacodynamics and efficacy of ACE2016 in patients with Locally Advanced or Metastatic Solid Tumors Expressing Epidermal Growth Factor Receptor (EGFR).
Recruiting
1 award
Phase 1
2 criteria
ART0380
for Advanced Cancer
This clinical trial is evaluating a drug called ART0380 in participants with advanced or metastatic solid tumors. The main goals of this study are to: * Find the recommended dose of ART0380 that can be given safely to participants alone and in combination with gemcitabine or irinotecan * Learn more about the side effects of ART0380 alone and in combination with gemcitabine or irinotecan * Learn more about the effectiveness of ART0380 alone and in combination with gemcitabine or irinotecan
Recruiting
1 award
Phase 1 & 2
14 criteria
More about Scott Paulson, MD
Clinical Trial Related
4 years of experience running clinical trials · Led 14 trials as a Principal Investigator · 3 Active Clinical Trials
Treatments Scott Paulson, MD has experience with
- Gemcitabine
- Placebo
- Nab-sirolimus
- Nab-paclitaxel
- 177Lu-Edotreotide
- Everolimus
Breakdown of trials Scott Paulson, MD has run
Pancreatic Cancer
Colorectal Cancer
Carcinoid Tumor
Hereditary Sensory Neuropathy
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Scott Paulson, MD specialize in?
Scott Paulson, MD focuses on Pancreatic Cancer and Colorectal Cancer. In particular, much of their work with Pancreatic Cancer has involved Stage IV patients, or patients who are Stage III.
Is Scott Paulson, MD currently recruiting for clinical trials?
Yes, Scott Paulson, MD is currently recruiting for 3 clinical trials in Dallas Texas. If you're interested in participating, you should apply.
Are there any treatments that Scott Paulson, MD has studied deeply?
Yes, Scott Paulson, MD has studied treatments such as Gemcitabine, Placebo, nab-sirolimus.
What is the best way to schedule an appointment with Scott Paulson, MD?
Apply for one of the trials that Scott Paulson, MD is conducting.
What is the office address of Scott Paulson, MD?
The office of Scott Paulson, MD is located at: Texas Oncology, Dallas, Texas 75246 United States. This is the address for their practice at the Texas Oncology.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.